HEADER TRANSFERASE 18-JAN-21 7BLE TITLE CO-CRYSTAL STRUCTURE OF HUMAN NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) TITLE 2 WITH THE TRICYCLIC INHIBITOR (3) COMPND MOL_ID: 1; COMPND 2 MOLECULE: NICOTINAMIDE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 2.1.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: DE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET28A KEYWDS METHYL TRANSFERASE, DRUG DISCOVERY, INHIBITOR COMPLEX, NICOTINAMIDE, KEYWDS 2 METABOLIC DISORDERS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.A.SCHREUDER,A.LIESUM REVDAT 2 31-JAN-24 7BLE 1 REMARK REVDAT 1 17-MAR-21 7BLE 0 JRNL AUTH A.KANNT,S.RAJAGOPAL,M.S.HALLUR,I.SWAMY,R.KRISTAM, JRNL AUTH 2 S.DHAKSHINAMOORTHY,J.CZECH,G.ZECH,H.SCHREUDER,S.RUF JRNL TITL NOVEL INHIBITORS OF NICOTINAMIDE- N -METHYLTRANSFERASE FOR JRNL TITL 2 THE TREATMENT OF METABOLIC DISORDERS. JRNL REF MOLECULES V. 26 2021 JRNL REFN ESSN 1420-3049 JRNL PMID 33668468 JRNL DOI 10.3390/MOLECULES26040991 REMARK 2 REMARK 2 RESOLUTION. 2.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (6-FEB-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 25753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1295 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.81 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1997 REMARK 3 BIN FREE R VALUE : 0.3876 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 24 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 164 REMARK 3 SOLVENT ATOMS : 274 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.50930 REMARK 3 B22 (A**2) : 6.56960 REMARK 3 B33 (A**2) : 1.93970 REMARK 3 B12 (A**2) : 0.94990 REMARK 3 B13 (A**2) : -4.33470 REMARK 3 B23 (A**2) : 1.66550 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.423 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.905 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.815 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8368 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11350 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2892 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1422 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8368 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1068 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6939 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7BLE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1292113544. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00004 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25804 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.809 REMARK 200 RESOLUTION RANGE LOW (A) : 57.636 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.28200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 2IIP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HUMAN NNMT WAS CRYSTALLIZED USING THE REMARK 280 FOLLOWING CONDITIONS: A PROTEIN SOLUTION WITH 6 MG/ML NNMT, 50 REMARK 280 MM TRIS/HCL, PH 8.0, 1 MM DTT, 86UM S-ADENOSYL-L-HOMOCYSTEINE REMARK 280 (SAH), 0.95MM INHIBITOR AND 5% V/V GLYCEROL WAS EQUILIBRATED AT REMARK 280 ROOM TEMPERATURE IN A HANGING DROP SETUP AGAINST 2.2 M AMMONIUM REMARK 280 SULFATE WITH 0.1 M HEPES/NA, PH 7.6. SMALL CRYSTAL APPEARED REMARK 280 AFTER 1-2 WEEKS., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 SER A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 SER A -8 REMARK 465 PHE A 27 REMARK 465 GLY A 28 REMARK 465 SER A 29 REMARK 465 SER A 261 REMARK 465 ARG A 262 REMARK 465 PRO A 263 REMARK 465 LEU A 264 REMARK 465 MET B -18 REMARK 465 GLY B -17 REMARK 465 SER B -16 REMARK 465 SER B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 SER B -8 REMARK 465 LYS B 26 REMARK 465 PHE B 27 REMARK 465 GLY B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 SER B 261 REMARK 465 ARG B 262 REMARK 465 PRO B 263 REMARK 465 LEU B 264 REMARK 465 MET C -18 REMARK 465 GLY C -17 REMARK 465 SER C -16 REMARK 465 SER C -15 REMARK 465 HIS C -14 REMARK 465 HIS C -13 REMARK 465 HIS C -12 REMARK 465 HIS C -11 REMARK 465 HIS C -10 REMARK 465 HIS C -9 REMARK 465 SER C -8 REMARK 465 SER C -7 REMARK 465 GLY C -6 REMARK 465 LEU C -5 REMARK 465 VAL C -4 REMARK 465 PRO C -3 REMARK 465 ARG C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 SER C 3 REMARK 465 PHE C 27 REMARK 465 GLY C 28 REMARK 465 SER C 29 REMARK 465 ARG C 30 REMARK 465 HIS C 31 REMARK 465 SER C 261 REMARK 465 ARG C 262 REMARK 465 PRO C 263 REMARK 465 LEU C 264 REMARK 465 MET D -18 REMARK 465 GLY D -17 REMARK 465 SER D -16 REMARK 465 SER D -15 REMARK 465 HIS D -14 REMARK 465 HIS D -13 REMARK 465 HIS D -12 REMARK 465 HIS D -11 REMARK 465 HIS D -10 REMARK 465 HIS D -9 REMARK 465 SER D -8 REMARK 465 SER D -7 REMARK 465 GLY D -6 REMARK 465 LEU D -5 REMARK 465 VAL D -4 REMARK 465 PRO D -3 REMARK 465 ARG D -2 REMARK 465 GLY D -1 REMARK 465 SER D 0 REMARK 465 MET D 1 REMARK 465 GLU D 2 REMARK 465 SER D 3 REMARK 465 PHE D 27 REMARK 465 GLY D 28 REMARK 465 SER D 29 REMARK 465 ARG D 30 REMARK 465 HIS D 31 REMARK 465 SER D 261 REMARK 465 ARG D 262 REMARK 465 PRO D 263 REMARK 465 LEU D 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A -2 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 30 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 31 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B -2 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 31 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 31 46.44 -103.17 REMARK 500 SER A 32 170.77 -50.24 REMARK 500 VAL A 54 78.96 -114.46 REMARK 500 ASP A 57 -68.78 -97.94 REMARK 500 VAL A 152 108.14 -55.58 REMARK 500 LEU A 164 44.57 39.09 REMARK 500 CYS A 165 -53.48 -125.88 REMARK 500 GLN B 70 1.55 -69.92 REMARK 500 CYS B 165 -50.73 -120.26 REMARK 500 THR B 245 36.92 -99.50 REMARK 500 MET B 246 -47.87 -136.01 REMARK 500 GLU B 250 57.76 -113.07 REMARK 500 PHE C 5 144.76 72.01 REMARK 500 ALA C 103 14.23 -68.36 REMARK 500 GLU C 118 24.31 -79.72 REMARK 500 MET C 246 -45.36 -130.49 REMARK 500 ASN C 248 33.14 -92.03 REMARK 500 ALA D 104 154.36 -46.84 REMARK 500 SER D 162 116.49 -161.98 REMARK 500 GLU D 208 -4.65 66.16 REMARK 500 GLU D 250 71.25 -115.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4168 DISTANCE = 7.90 ANGSTROMS REMARK 525 HOH A4169 DISTANCE = 10.91 ANGSTROMS REMARK 525 HOH B4185 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH C4156 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH D4163 DISTANCE = 6.68 ANGSTROMS REMARK 525 HOH D4164 DISTANCE = 7.27 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SAH A 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U1W A 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SAH B 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U1W B 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SAH C 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U1W C 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SAH D 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U1W D 4002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7BKG RELATED DB: PDB REMARK 900 SAME PROTEIN WITH DIFFERENT INHIBITOR DBREF 7BLE A 1 264 UNP P40261 NNMT_HUMAN 1 264 DBREF 7BLE B 1 264 UNP P40261 NNMT_HUMAN 1 264 DBREF 7BLE C 1 264 UNP P40261 NNMT_HUMAN 1 264 DBREF 7BLE D 1 264 UNP P40261 NNMT_HUMAN 1 264 SEQADV 7BLE MET A -18 UNP P40261 INITIATING METHIONINE SEQADV 7BLE GLY A -17 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER A -16 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER A -15 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -14 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -13 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -12 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -11 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -10 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS A -9 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER A -8 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER A -7 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY A -6 UNP P40261 EXPRESSION TAG SEQADV 7BLE LEU A -5 UNP P40261 EXPRESSION TAG SEQADV 7BLE VAL A -4 UNP P40261 EXPRESSION TAG SEQADV 7BLE PRO A -3 UNP P40261 EXPRESSION TAG SEQADV 7BLE ARG A -2 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY A -1 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER A 0 UNP P40261 EXPRESSION TAG SEQADV 7BLE ALA A 100 UNP P40261 LYS 100 ENGINEERED MUTATION SEQADV 7BLE ALA A 101 UNP P40261 GLU 101 ENGINEERED MUTATION SEQADV 7BLE ALA A 103 UNP P40261 GLU 103 ENGINEERED MUTATION SEQADV 7BLE MET B -18 UNP P40261 INITIATING METHIONINE SEQADV 7BLE GLY B -17 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER B -16 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER B -15 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -14 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -13 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -12 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -11 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -10 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS B -9 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER B -8 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER B -7 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY B -6 UNP P40261 EXPRESSION TAG SEQADV 7BLE LEU B -5 UNP P40261 EXPRESSION TAG SEQADV 7BLE VAL B -4 UNP P40261 EXPRESSION TAG SEQADV 7BLE PRO B -3 UNP P40261 EXPRESSION TAG SEQADV 7BLE ARG B -2 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY B -1 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER B 0 UNP P40261 EXPRESSION TAG SEQADV 7BLE ALA B 100 UNP P40261 LYS 100 ENGINEERED MUTATION SEQADV 7BLE ALA B 101 UNP P40261 GLU 101 ENGINEERED MUTATION SEQADV 7BLE ALA B 103 UNP P40261 GLU 103 ENGINEERED MUTATION SEQADV 7BLE MET C -18 UNP P40261 INITIATING METHIONINE SEQADV 7BLE GLY C -17 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER C -16 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER C -15 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -14 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -13 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -12 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -11 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -10 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS C -9 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER C -8 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER C -7 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY C -6 UNP P40261 EXPRESSION TAG SEQADV 7BLE LEU C -5 UNP P40261 EXPRESSION TAG SEQADV 7BLE VAL C -4 UNP P40261 EXPRESSION TAG SEQADV 7BLE PRO C -3 UNP P40261 EXPRESSION TAG SEQADV 7BLE ARG C -2 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY C -1 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER C 0 UNP P40261 EXPRESSION TAG SEQADV 7BLE ALA C 100 UNP P40261 LYS 100 ENGINEERED MUTATION SEQADV 7BLE ALA C 101 UNP P40261 GLU 101 ENGINEERED MUTATION SEQADV 7BLE ALA C 103 UNP P40261 GLU 103 ENGINEERED MUTATION SEQADV 7BLE MET D -18 UNP P40261 INITIATING METHIONINE SEQADV 7BLE GLY D -17 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER D -16 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER D -15 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -14 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -13 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -12 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -11 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -10 UNP P40261 EXPRESSION TAG SEQADV 7BLE HIS D -9 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER D -8 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER D -7 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY D -6 UNP P40261 EXPRESSION TAG SEQADV 7BLE LEU D -5 UNP P40261 EXPRESSION TAG SEQADV 7BLE VAL D -4 UNP P40261 EXPRESSION TAG SEQADV 7BLE PRO D -3 UNP P40261 EXPRESSION TAG SEQADV 7BLE ARG D -2 UNP P40261 EXPRESSION TAG SEQADV 7BLE GLY D -1 UNP P40261 EXPRESSION TAG SEQADV 7BLE SER D 0 UNP P40261 EXPRESSION TAG SEQADV 7BLE ALA D 100 UNP P40261 LYS 100 ENGINEERED MUTATION SEQADV 7BLE ALA D 101 UNP P40261 GLU 101 ENGINEERED MUTATION SEQADV 7BLE ALA D 103 UNP P40261 GLU 103 ENGINEERED MUTATION SEQRES 1 A 283 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 283 LEU VAL PRO ARG GLY SER MET GLU SER GLY PHE THR SER SEQRES 3 A 283 LYS ASP THR TYR LEU SER HIS PHE ASN PRO ARG ASP TYR SEQRES 4 A 283 LEU GLU LYS TYR TYR LYS PHE GLY SER ARG HIS SER ALA SEQRES 5 A 283 GLU SER GLN ILE LEU LYS HIS LEU LEU LYS ASN LEU PHE SEQRES 6 A 283 LYS ILE PHE CYS LEU ASP GLY VAL LYS GLY ASP LEU LEU SEQRES 7 A 283 ILE ASP ILE GLY SER GLY PRO THR ILE TYR GLN LEU LEU SEQRES 8 A 283 SER ALA CYS GLU SER PHE LYS GLU ILE VAL VAL THR ASP SEQRES 9 A 283 TYR SER ASP GLN ASN LEU GLN GLU LEU GLU LYS TRP LEU SEQRES 10 A 283 LYS ALA ALA PRO ALA ALA PHE ASP TRP SER PRO VAL VAL SEQRES 11 A 283 THR TYR VAL CYS ASP LEU GLU GLY ASN ARG VAL LYS GLY SEQRES 12 A 283 PRO GLU LYS GLU GLU LYS LEU ARG GLN ALA VAL LYS GLN SEQRES 13 A 283 VAL LEU LYS CYS ASP VAL THR GLN SER GLN PRO LEU GLY SEQRES 14 A 283 ALA VAL PRO LEU PRO PRO ALA ASP CYS VAL LEU SER THR SEQRES 15 A 283 LEU CYS LEU ASP ALA ALA CYS PRO ASP LEU PRO THR TYR SEQRES 16 A 283 CYS ARG ALA LEU ARG ASN LEU GLY SER LEU LEU LYS PRO SEQRES 17 A 283 GLY GLY PHE LEU VAL ILE MET ASP ALA LEU LYS SER SER SEQRES 18 A 283 TYR TYR MET ILE GLY GLU GLN LYS PHE SER SER LEU PRO SEQRES 19 A 283 LEU GLY ARG GLU ALA VAL GLU ALA ALA VAL LYS GLU ALA SEQRES 20 A 283 GLY TYR THR ILE GLU TRP PHE GLU VAL ILE SER GLN SER SEQRES 21 A 283 TYR SER SER THR MET ALA ASN ASN GLU GLY LEU PHE SER SEQRES 22 A 283 LEU VAL ALA ARG LYS LEU SER ARG PRO LEU SEQRES 1 B 283 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 283 LEU VAL PRO ARG GLY SER MET GLU SER GLY PHE THR SER SEQRES 3 B 283 LYS ASP THR TYR LEU SER HIS PHE ASN PRO ARG ASP TYR SEQRES 4 B 283 LEU GLU LYS TYR TYR LYS PHE GLY SER ARG HIS SER ALA SEQRES 5 B 283 GLU SER GLN ILE LEU LYS HIS LEU LEU LYS ASN LEU PHE SEQRES 6 B 283 LYS ILE PHE CYS LEU ASP GLY VAL LYS GLY ASP LEU LEU SEQRES 7 B 283 ILE ASP ILE GLY SER GLY PRO THR ILE TYR GLN LEU LEU SEQRES 8 B 283 SER ALA CYS GLU SER PHE LYS GLU ILE VAL VAL THR ASP SEQRES 9 B 283 TYR SER ASP GLN ASN LEU GLN GLU LEU GLU LYS TRP LEU SEQRES 10 B 283 LYS ALA ALA PRO ALA ALA PHE ASP TRP SER PRO VAL VAL SEQRES 11 B 283 THR TYR VAL CYS ASP LEU GLU GLY ASN ARG VAL LYS GLY SEQRES 12 B 283 PRO GLU LYS GLU GLU LYS LEU ARG GLN ALA VAL LYS GLN SEQRES 13 B 283 VAL LEU LYS CYS ASP VAL THR GLN SER GLN PRO LEU GLY SEQRES 14 B 283 ALA VAL PRO LEU PRO PRO ALA ASP CYS VAL LEU SER THR SEQRES 15 B 283 LEU CYS LEU ASP ALA ALA CYS PRO ASP LEU PRO THR TYR SEQRES 16 B 283 CYS ARG ALA LEU ARG ASN LEU GLY SER LEU LEU LYS PRO SEQRES 17 B 283 GLY GLY PHE LEU VAL ILE MET ASP ALA LEU LYS SER SER SEQRES 18 B 283 TYR TYR MET ILE GLY GLU GLN LYS PHE SER SER LEU PRO SEQRES 19 B 283 LEU GLY ARG GLU ALA VAL GLU ALA ALA VAL LYS GLU ALA SEQRES 20 B 283 GLY TYR THR ILE GLU TRP PHE GLU VAL ILE SER GLN SER SEQRES 21 B 283 TYR SER SER THR MET ALA ASN ASN GLU GLY LEU PHE SER SEQRES 22 B 283 LEU VAL ALA ARG LYS LEU SER ARG PRO LEU SEQRES 1 C 283 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 283 LEU VAL PRO ARG GLY SER MET GLU SER GLY PHE THR SER SEQRES 3 C 283 LYS ASP THR TYR LEU SER HIS PHE ASN PRO ARG ASP TYR SEQRES 4 C 283 LEU GLU LYS TYR TYR LYS PHE GLY SER ARG HIS SER ALA SEQRES 5 C 283 GLU SER GLN ILE LEU LYS HIS LEU LEU LYS ASN LEU PHE SEQRES 6 C 283 LYS ILE PHE CYS LEU ASP GLY VAL LYS GLY ASP LEU LEU SEQRES 7 C 283 ILE ASP ILE GLY SER GLY PRO THR ILE TYR GLN LEU LEU SEQRES 8 C 283 SER ALA CYS GLU SER PHE LYS GLU ILE VAL VAL THR ASP SEQRES 9 C 283 TYR SER ASP GLN ASN LEU GLN GLU LEU GLU LYS TRP LEU SEQRES 10 C 283 LYS ALA ALA PRO ALA ALA PHE ASP TRP SER PRO VAL VAL SEQRES 11 C 283 THR TYR VAL CYS ASP LEU GLU GLY ASN ARG VAL LYS GLY SEQRES 12 C 283 PRO GLU LYS GLU GLU LYS LEU ARG GLN ALA VAL LYS GLN SEQRES 13 C 283 VAL LEU LYS CYS ASP VAL THR GLN SER GLN PRO LEU GLY SEQRES 14 C 283 ALA VAL PRO LEU PRO PRO ALA ASP CYS VAL LEU SER THR SEQRES 15 C 283 LEU CYS LEU ASP ALA ALA CYS PRO ASP LEU PRO THR TYR SEQRES 16 C 283 CYS ARG ALA LEU ARG ASN LEU GLY SER LEU LEU LYS PRO SEQRES 17 C 283 GLY GLY PHE LEU VAL ILE MET ASP ALA LEU LYS SER SER SEQRES 18 C 283 TYR TYR MET ILE GLY GLU GLN LYS PHE SER SER LEU PRO SEQRES 19 C 283 LEU GLY ARG GLU ALA VAL GLU ALA ALA VAL LYS GLU ALA SEQRES 20 C 283 GLY TYR THR ILE GLU TRP PHE GLU VAL ILE SER GLN SER SEQRES 21 C 283 TYR SER SER THR MET ALA ASN ASN GLU GLY LEU PHE SER SEQRES 22 C 283 LEU VAL ALA ARG LYS LEU SER ARG PRO LEU SEQRES 1 D 283 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 D 283 LEU VAL PRO ARG GLY SER MET GLU SER GLY PHE THR SER SEQRES 3 D 283 LYS ASP THR TYR LEU SER HIS PHE ASN PRO ARG ASP TYR SEQRES 4 D 283 LEU GLU LYS TYR TYR LYS PHE GLY SER ARG HIS SER ALA SEQRES 5 D 283 GLU SER GLN ILE LEU LYS HIS LEU LEU LYS ASN LEU PHE SEQRES 6 D 283 LYS ILE PHE CYS LEU ASP GLY VAL LYS GLY ASP LEU LEU SEQRES 7 D 283 ILE ASP ILE GLY SER GLY PRO THR ILE TYR GLN LEU LEU SEQRES 8 D 283 SER ALA CYS GLU SER PHE LYS GLU ILE VAL VAL THR ASP SEQRES 9 D 283 TYR SER ASP GLN ASN LEU GLN GLU LEU GLU LYS TRP LEU SEQRES 10 D 283 LYS ALA ALA PRO ALA ALA PHE ASP TRP SER PRO VAL VAL SEQRES 11 D 283 THR TYR VAL CYS ASP LEU GLU GLY ASN ARG VAL LYS GLY SEQRES 12 D 283 PRO GLU LYS GLU GLU LYS LEU ARG GLN ALA VAL LYS GLN SEQRES 13 D 283 VAL LEU LYS CYS ASP VAL THR GLN SER GLN PRO LEU GLY SEQRES 14 D 283 ALA VAL PRO LEU PRO PRO ALA ASP CYS VAL LEU SER THR SEQRES 15 D 283 LEU CYS LEU ASP ALA ALA CYS PRO ASP LEU PRO THR TYR SEQRES 16 D 283 CYS ARG ALA LEU ARG ASN LEU GLY SER LEU LEU LYS PRO SEQRES 17 D 283 GLY GLY PHE LEU VAL ILE MET ASP ALA LEU LYS SER SER SEQRES 18 D 283 TYR TYR MET ILE GLY GLU GLN LYS PHE SER SER LEU PRO SEQRES 19 D 283 LEU GLY ARG GLU ALA VAL GLU ALA ALA VAL LYS GLU ALA SEQRES 20 D 283 GLY TYR THR ILE GLU TRP PHE GLU VAL ILE SER GLN SER SEQRES 21 D 283 TYR SER SER THR MET ALA ASN ASN GLU GLY LEU PHE SER SEQRES 22 D 283 LEU VAL ALA ARG LYS LEU SER ARG PRO LEU HET SAH A4001 26 HET U1W A4002 15 HET SAH B4001 26 HET U1W B4002 15 HET SAH C4001 26 HET U1W C4002 15 HET SAH D4001 26 HET U1W D4002 15 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM U1W 3-ETHYL-1,3-DIAZATRICYCLO[6.3.1.0^{4,12}]DODECA-4,6, HETNAM 2 U1W 8(12)-TRIEN-2-IMINE FORMUL 5 SAH 4(C14 H20 N6 O5 S) FORMUL 6 U1W 4(C12 H15 N3) FORMUL 13 HOH *274(H2 O) HELIX 1 AA1 SER A 7 HIS A 14 1 8 HELIX 2 AA2 ASN A 16 TYR A 25 1 10 HELIX 3 AA3 SER A 32 LEU A 51 1 20 HELIX 4 AA4 SER A 73 GLU A 76 5 4 HELIX 5 AA5 SER A 87 LYS A 99 1 13 HELIX 6 AA6 TRP A 107 GLU A 118 1 12 HELIX 7 AA7 LYS A 123 ALA A 134 1 12 HELIX 8 AA8 CYS A 165 CYS A 170 1 6 HELIX 9 AA9 ASP A 172 SER A 185 1 14 HELIX 10 AB1 GLY A 217 ALA A 228 1 12 HELIX 11 AB2 SER B 7 TYR B 11 5 5 HELIX 12 AB3 ASN B 16 TYR B 25 1 10 HELIX 13 AB4 SER B 32 LEU B 51 1 20 HELIX 14 AB5 ILE B 68 GLU B 76 5 9 HELIX 15 AB6 SER B 87 LYS B 99 1 13 HELIX 16 AB7 TRP B 107 GLU B 118 1 12 HELIX 17 AB8 LYS B 123 ALA B 134 1 12 HELIX 18 AB9 CYS B 165 CYS B 170 1 6 HELIX 19 AC1 ASP B 172 SER B 185 1 14 HELIX 20 AC2 GLY B 217 ALA B 228 1 12 HELIX 21 AC3 SER C 7 LEU C 12 5 6 HELIX 22 AC4 ASN C 16 TYR C 25 1 10 HELIX 23 AC5 ALA C 33 CYS C 50 1 18 HELIX 24 AC6 ILE C 68 LEU C 72 5 5 HELIX 25 AC7 SER C 73 SER C 77 1 5 HELIX 26 AC8 SER C 87 LYS C 99 1 13 HELIX 27 AC9 TRP C 107 GLU C 118 1 12 HELIX 28 AD1 LYS C 123 ALA C 134 1 12 HELIX 29 AD2 CYS C 165 CYS C 170 1 6 HELIX 30 AD3 ASP C 172 LEU C 186 1 15 HELIX 31 AD4 GLY C 217 ALA C 228 1 12 HELIX 32 AD5 SER D 7 LEU D 12 1 6 HELIX 33 AD6 ASN D 16 TYR D 25 1 10 HELIX 34 AD7 ALA D 33 LEU D 51 1 19 HELIX 35 AD8 ILE D 68 LEU D 72 5 5 HELIX 36 AD9 SER D 73 SER D 77 1 5 HELIX 37 AE1 SER D 87 LYS D 99 1 13 HELIX 38 AE2 TRP D 107 GLU D 118 1 12 HELIX 39 AE3 LYS D 123 ALA D 134 1 12 HELIX 40 AE4 CYS D 165 CYS D 170 1 6 HELIX 41 AE5 ASP D 172 LEU D 186 1 15 HELIX 42 AE6 GLY D 217 ALA D 228 1 12 SHEET 1 AA1 7 VAL A 135 LYS A 140 0 SHEET 2 AA1 7 PHE A 78 ASP A 85 1 N ILE A 81 O LYS A 136 SHEET 3 AA1 7 GLY A 56 ASP A 61 1 N ASP A 61 O VAL A 82 SHEET 4 AA1 7 ALA A 157 THR A 163 1 O ASP A 158 N LEU A 58 SHEET 5 AA1 7 LEU A 187 ALA A 198 1 O VAL A 194 N VAL A 160 SHEET 6 AA1 7 LEU A 252 LYS A 259 -1 O ALA A 257 N LEU A 193 SHEET 7 AA1 7 TYR A 230 ILE A 238 -1 N GLU A 236 O SER A 254 SHEET 1 AA2 2 TYR A 203 ILE A 206 0 SHEET 2 AA2 2 GLN A 209 SER A 212 -1 O PHE A 211 N TYR A 204 SHEET 1 AA3 7 VAL B 135 LYS B 140 0 SHEET 2 AA3 7 PHE B 78 ASP B 85 1 N VAL B 83 O LEU B 139 SHEET 3 AA3 7 GLY B 56 ASP B 61 1 N ASP B 61 O VAL B 82 SHEET 4 AA3 7 ALA B 157 THR B 163 1 O LEU B 161 N ILE B 60 SHEET 5 AA3 7 LEU B 187 ALA B 198 1 O VAL B 194 N VAL B 160 SHEET 6 AA3 7 LEU B 252 LYS B 259 -1 O ALA B 257 N LEU B 193 SHEET 7 AA3 7 TYR B 230 ILE B 238 -1 N GLU B 233 O VAL B 256 SHEET 1 AA4 2 TYR B 203 ILE B 206 0 SHEET 2 AA4 2 GLN B 209 SER B 212 -1 O GLN B 209 N ILE B 206 SHEET 1 AA5 7 VAL C 135 LYS C 140 0 SHEET 2 AA5 7 PHE C 78 ASP C 85 1 N VAL C 83 O GLN C 137 SHEET 3 AA5 7 GLY C 56 ASP C 61 1 N ASP C 61 O VAL C 82 SHEET 4 AA5 7 ALA C 157 THR C 163 1 O LEU C 161 N ILE C 60 SHEET 5 AA5 7 LEU C 187 ALA C 198 1 O VAL C 194 N VAL C 160 SHEET 6 AA5 7 LEU C 252 LYS C 259 -1 O PHE C 253 N ASP C 197 SHEET 7 AA5 7 TYR C 230 ILE C 238 -1 N GLU C 236 O SER C 254 SHEET 1 AA6 2 TYR C 203 ILE C 206 0 SHEET 2 AA6 2 GLN C 209 SER C 212 -1 O GLN C 209 N ILE C 206 SHEET 1 AA7 7 VAL D 135 LYS D 140 0 SHEET 2 AA7 7 PHE D 78 ASP D 85 1 N VAL D 83 O GLN D 137 SHEET 3 AA7 7 GLY D 56 ASP D 61 1 N ASP D 61 O VAL D 82 SHEET 4 AA7 7 ALA D 157 THR D 163 1 O LEU D 161 N ILE D 60 SHEET 5 AA7 7 LEU D 187 ALA D 198 1 O VAL D 194 N VAL D 160 SHEET 6 AA7 7 LEU D 252 LYS D 259 -1 O PHE D 253 N ASP D 197 SHEET 7 AA7 7 TYR D 230 ILE D 238 -1 N THR D 231 O ARG D 258 SHEET 1 AA8 2 TYR D 203 ILE D 206 0 SHEET 2 AA8 2 GLN D 209 SER D 212 -1 O PHE D 211 N TYR D 204 SITE 1 AC1 21 TYR A 11 TYR A 20 TYR A 25 GLY A 63 SITE 2 AC1 21 SER A 64 GLY A 65 THR A 67 TYR A 69 SITE 3 AC1 21 ASP A 85 TYR A 86 SER A 87 ASN A 90 SITE 4 AC1 21 CYS A 141 ASP A 142 VAL A 143 THR A 163 SITE 5 AC1 21 LEU A 164 CYS A 165 ALA A 169 U1W A4002 SITE 6 AC1 21 HOH A4113 SITE 1 AC2 12 TYR A 20 TYR A 24 TYR A 25 LEU A 164 SITE 2 AC2 12 ALA A 168 ALA A 198 SER A 201 TYR A 204 SITE 3 AC2 12 SER A 213 TYR A 242 ALA A 247 SAH A4001 SITE 1 AC3 20 TYR B 11 TYR B 20 TYR B 25 GLY B 63 SITE 2 AC3 20 SER B 64 GLY B 65 THR B 67 TYR B 69 SITE 3 AC3 20 ASP B 85 TYR B 86 SER B 87 ASN B 90 SITE 4 AC3 20 CYS B 141 ASP B 142 VAL B 143 THR B 163 SITE 5 AC3 20 LEU B 164 CYS B 165 ALA B 169 U1W B4002 SITE 1 AC4 10 TYR B 20 TYR B 24 LEU B 164 ALA B 198 SITE 2 AC4 10 SER B 201 TYR B 204 SER B 213 TYR B 242 SITE 3 AC4 10 ALA B 247 SAH B4001 SITE 1 AC5 20 TYR C 11 TYR C 20 TYR C 25 GLY C 63 SITE 2 AC5 20 SER C 64 GLY C 65 THR C 67 TYR C 69 SITE 3 AC5 20 GLN C 70 ASP C 85 TYR C 86 SER C 87 SITE 4 AC5 20 ASN C 90 CYS C 141 ASP C 142 VAL C 143 SITE 5 AC5 20 THR C 163 LEU C 164 CYS C 165 U1W C4002 SITE 1 AC6 9 TYR C 20 TYR C 25 LEU C 164 ALA C 198 SITE 2 AC6 9 SER C 201 SER C 213 TYR C 242 ALA C 247 SITE 3 AC6 9 SAH C4001 SITE 1 AC7 18 TYR D 11 TYR D 20 TYR D 25 GLY D 63 SITE 2 AC7 18 SER D 64 GLY D 65 THR D 67 TYR D 69 SITE 3 AC7 18 ASP D 85 TYR D 86 SER D 87 ASN D 90 SITE 4 AC7 18 CYS D 141 ASP D 142 VAL D 143 THR D 163 SITE 5 AC7 18 LEU D 164 U1W D4002 SITE 1 AC8 12 TYR D 20 TYR D 24 TYR D 25 LEU D 164 SITE 2 AC8 12 ALA D 168 ASP D 197 SER D 201 TYR D 204 SITE 3 AC8 12 SER D 213 TYR D 242 ALA D 247 SAH D4001 CRYST1 45.714 62.189 107.690 91.51 98.09 111.54 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021875 0.008634 0.003855 0.00000 SCALE2 0.000000 0.017287 0.001470 0.00000 SCALE3 0.000000 0.000000 0.009413 0.00000